WallStreetZenWallStreetZen

NASDAQ: LIFE
Atyr Pharma Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

LIFE past revenue growth

How has LIFE's revenue growth performed historically?
Company
N/A
Industry
110.58%
Market
14.02%
LIFE's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
LIFE's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance

LIFE earnings and revenue history

Current Revenue
$10.7M
Current Earnings
-$43.2M
Current Profit Margin
-401.8%

LIFE Return on Equity

Current Company
-44.7%
Current Industry
15.6%
Current Market
-8.4%
LIFE's Return on Equity (-44.7%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when LIFE announces earnings.

LIFE Return on Assets

Current Company
-35.2%
Current Industry
2.2%
LIFE is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

LIFE Return on Capital Employed

Current Company
-38.46%
Current Industry
17.7%
LIFE has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

LIFE vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
LIFE$10.74M-$40.12M-$43.15M+149.30%N/A
SPRO$77.70M$1.06M-$1.61M+88.47%-64.99%
COYA$0.00-$12.33M-$12.36MN/AN/A
NGM$0.00-$146.77M-$151.14MN/AN/A
LPTX$0.00-$80.88M-$81.05M-100.00%N/A
View Top Biotech Stocks

Atyr Pharma Earnings & Revenue FAQ

What were LIFE's earnings last quarter?

On Invalid Date, Atyr Pharma (NASDAQ: LIFE) reported Q3 2023 earnings per share (EPS) of -$0.20, up 56.52% year over year. Total Atyr Pharma earnings for the quarter were -$11.34 million. In the same quarter last year, Atyr Pharma's earnings per share (EPS) was -$0.46.

If you're new to stock investing, here's how to buy Atyr Pharma stock.

What was LIFE's earnings growth in the past year?

As of Q4 2023, Atyr Pharma's earnings has grown year over year. Atyr Pharma's earnings in the past year totalled -$43.15 million.

What was LIFE's revenue last quarter?

On Invalid Date, Atyr Pharma (NASDAQ: LIFE) reported Q3 2023 revenue of $353.00 thousand up Infinity% year over year. In the same quarter last year, Atyr Pharma's revenue was $0.00.

What was LIFE's revenue growth in the past year?

As of Q4 2023, Atyr Pharma's revenue has grown null year over year. Atyr Pharma's revenue in the past year totalled $10.74 million.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.